Аналитика NYSE на 10 октября

Спайдер повышается перед открытием торгов на NYSE.

Европейские индексы на положительной территории.

SPY (внутридневной график) аптренд премаркете. Поддержка 166.00, сопротивление 167.00
Премаркет NYSE/NASDAQ:
Gapping up:

In reaction to strong earnings/guidance/SSS: DRWI +11.1% (light volume), IGTE +8.4%, SYNA +0.8% (to pay ~$92.5 mln in cash and stock to acquire Validity Sensors; co sees Q1 revs of $220 mln vs $206.31 Capital IQ Consensus Estimate).
M&A news: PVR +17.5% (Regency Energy Partners to Acquire PVR Partners for $5.6 Billion), JOSB +0.9% (Men's Wearhouse adopts limited duration Shareholder Rights Plan; Jos. A. Bank responds to Mens Wearhouse (MW); will cont to pursue $48 per share proposal).
Select financial related names showing strength: ING +3.7%, PUK +3%, DB +2.4%, HBC +1.4%.
With sharp gain in futures, momentum stocks leading gains after showing relative strength amid recent selloff: TSLA +3.4% DDD +2.3% NFLX +2.6% ( initiated with a Buy at Needham), GRPN +2.3%, FB +2.2%, YELP +2%

Solar names moving higher: CSIQ +6.9%, JKS +6.3%, RSOL +4%, SOL +3.4%, STP +3%, YGE +3%, SPWR +2.8%, FSLR +1.2%
China internet names seeing upside move: YY +3.6%, DANG +3.1%, BIDU +1.2%
Other news: ACUR +29% (Acura Pharma announces settlement of Oxecta patent litigation with Par Pharmaceutical and Impax Laboratories), CHTP +9% ( announces FDA Advisory Committee to review NORTHERA), ACAD +6.7% (rebounding), ALU +5.4% (still checking), CLDX +4.6% (still checking), TTM +4.2% (still checking), DVAX +3.5% (initiates first human trial in asthma program), TEVA +3.2% (Teva Pharma announced steps to accelerate the reduction of costs and to optimize its structure and processes; $2.0 bln in annual cost savings by the end of 2017 including $1.0 bln by the end of 2014; reaffirms FY13 guidance), GILD +3.1% (Gilead to Stop Phase 3 Study 116 of Idelalisib in Chronic Lymphocytic Leukemia Early Because of Positive Risk-Benefit), DRYS +2.7% (still checking), MU +2.5% (still checking), TASR +1.8% (enters into a definitive agreement to acquire Familiar; team will be joining EVIDENCE.com), SIRI +1.8% (Sirius XM Radio announces its Board of Directors has approved an additional $2 bln common stock repurchase program), IMMU +1.8% (announces termination of agreement and return of worldwide rights to veltuzumab for all non-cancer indications), ARUN +1.6% (announces additional $100 mln share repurchase authorization), LMT +1.6% (Lockheed Martin and US Air Force are close to $2.2 bln satellites deal, according to reports), NUAN +1.4% (announced that it has signed an agreement to acquire Varolii), YHOO +1.2% (still checking), STX +0.7% (following reports SSNLF selling stake back to the company).
Analyst comments: ODP +5.3% (upgraded to Buy from Neutral at Janney ), SSYS +3.3% (upgraded to Overweight from Neutral at JP Morgan), TI +2.2% (upgraded to Sector Perform from Underperform at RBC Capital ), FCH +2% (upgraded to Buy from Neutral at Goldman), HPQ +1.8% (upgraded to Neutral from Underperform at Mizuho), DFS +1.4% (upgraded to Buy from Neutral at Citigroup), BA +0.5% (Boeing initiated with a Buy at Canaccord Genuity), CHKP +0.4% (Check Point upgraded to Outperform from Market Perform at Cowen)

Gapping down:

In reaction to disappointing earnings/guidance: RT -13.9%, CTXS -12.7%, CKSW -9.7%, VOXX -6.9%, PRXI -6.6%, HUBG -4.4% (downgraded to Neutral from Outperform at Macquarie), BKE -3.2%, LNN -1.3%, HELE -1.2%, CVX -0.3%.
M&A news: MW -0.5% (Men's Wearhouse adopts limited duration Shareholder Rights Plan; Jos. A. Bank responds to Mens Wearhouse (MW); will cont to pursue $48 per share proposal).
CTXS peers are under pressure: NTAP -2.2%, VMW -1.8%, FFIV -1%, CRM -0.8%, EMC -0.6%, RHT -0.5%, JNPR -0.5%
Other news: CGR -7.3% (will voluntarily delist its common shares from the NYSE MKT), VISN -4.9% (continuing modest pullback), PCYC -2.9% (continued weakness), IRM -2.7% (Announces CFO Departure), BPL -2.3% (commences public offering of 6.5 mln limited partnership units representing limited partner interests; to Acquire Liquid Petroleum Products Terminals Network From Hess for $850 Million), CTRP -1.6% (announces proposed offering of $500 mln convertible senior notes), BBRY -1% (BlackBerry open to breakup of company, according to reports ), GTN -0.9% (following late spike; Bloomberg Real M&A reporting that SBGI could be looking to acquire GTN), HES -0.4% (Hess announces sale of terminal network for approx $850 mln in cash).
Analyst comments: LF -8.2% (downgraded to Neutral from Buy at Ascendiant), SNE -0.8% (downgraded to Neutral from Buy at Citigroup), RHP -0.7% (downgraded to Neutral from Buy at Goldman), GSK -0.4% ( downgraded to Underperform from Neutral at Credit Suisse).

Интересные новостные акции NYSEи NASDAQ:

ARUN – лонг выше 19.00
HPQ – лонг выше максимумов премаркета
IGTE – шорт ниже 29.00
TEVA – лонг выше максимума премаркета
INFY – лонг выше максимума премаркета
CTXS – лонг выше 60.00

Оригинал статьи: http://shark-traders.com/blog/analitika-nyse-na-10-oktyabrya/

NYSE NASDAQ research stocks in play отбор акций

Shark Traders

Санкт-Петербург

1 460

с 27 марта 2013

0 Комментариев

Читайте на SMART-LAB:

Глобальный евро по-тихому: что может означать расширение EUREP репо

Индекс доллара DXY сегодня сделал неуверенную попытку пробить 97 пунктов, но быстро свернул планы. Пока это выглядит как пауза перед событиями: в среду выйдут протокол прошедшего заседания FOMC,...

Tickmill

17.02.2026

Насколько вы довольны Mozgovik Research?

Mozgovik

17.02.2026

Арбитраж фьючерс vs базовый актив: почему расхождение есть всегда и где здесь деньги

Не все расхождения одинаково полезны Классическая идея арбитража простая. Hа двух рынках один и тот же актив стоит по-разному: покупаем дешевле, продаем дороже. Так можно сравнивать,...

Финам Брокер

17.02.2026

Россети Урал. Отчет об исполнении инвестпрограммы за Q4 2025г. Считаем дивиденды!

Компания Россети Урал опубликовала отчет об исполнении инвестпрограммы за Q4 2025г., где показаны финансовые показатели компании по РСБУ в 4 квартале (ну и понятно за целый год): 👉Выручка...